Key Details
Annual Revenue
$24.54 MAnnual ROE
-70.34%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 24, 2023Recent annual earnings:
Feb 24, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with OYST included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Oyster Point Pharma doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Oyster Point Pharma?
- What is the ticker symbol for Oyster Point Pharma?
- Does Oyster Point Pharma pay dividends?
- What sector is Oyster Point Pharma in?
- What industry is Oyster Point Pharma in?
- What country is Oyster Point Pharma based in?
- When did Oyster Point Pharma go public?
- Is Oyster Point Pharma in the S&P 500?
- Is Oyster Point Pharma in the NASDAQ 100?
- Is Oyster Point Pharma in the Dow Jones?
- When was Oyster Point Pharma's last earnings report?
- When does Oyster Point Pharma report earnings?
What is the primary business of Oyster Point Pharma?
Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company's lead product candidate is OC-01, a nicotinic acetylcholine receptor agonist that has completed Phase III clinical trial for the treatment of signs and symptoms of dry eye disease. It is also developing OC-01 for neurotrophic keratopathy. Oyster Point Pharma, Inc. was incorporated in 2015 and is headquartered in Princeton, New Jersey.
What is the ticker symbol for Oyster Point Pharma?
The ticker symbol for Oyster Point Pharma is NASDAQ:OYST
Does Oyster Point Pharma pay dividends?
No, Oyster Point Pharma does not pay dividends
What sector is Oyster Point Pharma in?
Oyster Point Pharma is in the Healthcare sector
What industry is Oyster Point Pharma in?
Oyster Point Pharma is in the Biotechnology industry
What country is Oyster Point Pharma based in?
Oyster Point Pharma is headquartered in United States
When did Oyster Point Pharma go public?
Oyster Point Pharma's initial public offering (IPO) was on 31 October 2019
Is Oyster Point Pharma in the S&P 500?
No, Oyster Point Pharma is not included in the S&P 500 index
Is Oyster Point Pharma in the NASDAQ 100?
No, Oyster Point Pharma is not included in the NASDAQ 100 index
Is Oyster Point Pharma in the Dow Jones?
No, Oyster Point Pharma is not included in the Dow Jones index
When was Oyster Point Pharma's last earnings report?
Oyster Point Pharma's most recent earnings report was on 24 February 2023
When does Oyster Point Pharma report earnings?
The date for Oyster Point Pharma's next earnings report has not been announced yet